Hard to understand MC being as low as it when owned our US manufacturing Complex / Metrics valuation around Companies entire MC company's turnover and assets impressive unfortunately we were saddled with impairments mainly our Teva debacle this impacted big time on Company's bottom line 5 years of heavy Net loses . Mayne after sale not the same company as it was when we owned Metrics an established manufacturing complex with profitable contracts with US Pharma companies . We were way undervalued considering solid assets surely an outstanding takeover opportunity for some large Pharma . Until management can prove itself and get Mayne now a much smaller company into net profit and our major product Nexstellis showing satisfactory sales can hardly expect MC being any higher than it is . Would have expected way more short term dividend interest , might be anticipating a downgrade by market analysts and risk getting stuck .
- Forums
- ASX - By Stock
- MYX
- Ann: Annual Report to shareholders
MYX
mayne pharma group limited
Add to My Watchlist
2.19%
!
$4.92

Ann: Annual Report to shareholders, page-41
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.92 |
Change
-0.110(2.19%) |
Mkt cap ! $399.7M |
Open | High | Low | Value | Volume |
$5.03 | $5.03 | $4.86 | $1.730M | 352.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $4.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.93 | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6000 | 4.870 |
2 | 10000 | 4.860 |
3 | 51300 | 4.850 |
1 | 600 | 4.840 |
2 | 2800 | 4.800 |
Price($) | Vol. | No. |
---|---|---|
4.930 | 25000 | 1 |
4.960 | 1303 | 1 |
4.980 | 1303 | 1 |
5.000 | 1303 | 1 |
5.020 | 1303 | 1 |
Last trade - 16.15pm 23/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |